FDA Inspection 1230748 — Invitron Advanced Analytics Private Limited

Invitron Advanced Analytics Private Limited — FEI 3013593602

The FDA completed an inspection of Invitron Advanced Analytics Private Limited on Nov 10, 2023 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 10, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hyderabad (India)

Additional Details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.